Copyright Reports & Markets. All rights reserved.

Global End-Stage Kidney Disease Treatment Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of End-Stage Kidney Disease Treatment

      • 1.1 Definition of End-Stage Kidney Disease Treatment
      • 1.2 End-Stage Kidney Disease Treatment Segment by Type
        • 1.2.1 Global End-Stage Kidney Disease Treatment Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 MK-3866
        • 1.2.3 Pacritinib
        • 1.2.4 Sanguinate
        • 1.2.5 Tesidolumab
        • 1.2.6 Others
      • 1.3 End-Stage Kidney Disease Treatment Segment by Applications
        • 1.3.1 Global End-Stage Kidney Disease Treatment Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Clinic
        • 1.3.3 Hospital
        • 1.3.4 Others
      • 1.4 Global End-Stage Kidney Disease Treatment Overall Market
        • 1.4.1 Global End-Stage Kidney Disease Treatment Revenue (2014-2025)
        • 1.4.2 Global End-Stage Kidney Disease Treatment Production (2014-2025)
        • 1.4.3 North America End-Stage Kidney Disease Treatment Status and Prospect (2014-2025)
        • 1.4.4 Europe End-Stage Kidney Disease Treatment Status and Prospect (2014-2025)
        • 1.4.5 China End-Stage Kidney Disease Treatment Status and Prospect (2014-2025)
        • 1.4.6 Japan End-Stage Kidney Disease Treatment Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia End-Stage Kidney Disease Treatment Status and Prospect (2014-2025)
        • 1.4.8 India End-Stage Kidney Disease Treatment Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of End-Stage Kidney Disease Treatment
      • 2.3 Manufacturing Process Analysis of End-Stage Kidney Disease Treatment
      • 2.4 Industry Chain Structure of End-Stage Kidney Disease Treatment

      3 Development and Manufacturing Plants Analysis of End-Stage Kidney Disease Treatment

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global End-Stage Kidney Disease Treatment Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of End-Stage Kidney Disease Treatment
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 End-Stage Kidney Disease Treatment Production and Capacity Analysis
      • 4.2 End-Stage Kidney Disease Treatment Revenue Analysis
      • 4.3 End-Stage Kidney Disease Treatment Price Analysis
      • 4.4 Market Concentration Degree

      5 End-Stage Kidney Disease Treatment Regional Market Analysis

      • 5.1 End-Stage Kidney Disease Treatment Production by Regions
        • 5.1.1 Global End-Stage Kidney Disease Treatment Production by Regions
        • 5.1.2 Global End-Stage Kidney Disease Treatment Revenue by Regions
      • 5.2 End-Stage Kidney Disease Treatment Consumption by Regions
      • 5.3 North America End-Stage Kidney Disease Treatment Market Analysis
        • 5.3.1 North America End-Stage Kidney Disease Treatment Production
        • 5.3.2 North America End-Stage Kidney Disease Treatment Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America End-Stage Kidney Disease Treatment Import and Export
      • 5.4 Europe End-Stage Kidney Disease Treatment Market Analysis
        • 5.4.1 Europe End-Stage Kidney Disease Treatment Production
        • 5.4.2 Europe End-Stage Kidney Disease Treatment Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe End-Stage Kidney Disease Treatment Import and Export
      • 5.5 China End-Stage Kidney Disease Treatment Market Analysis
        • 5.5.1 China End-Stage Kidney Disease Treatment Production
        • 5.5.2 China End-Stage Kidney Disease Treatment Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China End-Stage Kidney Disease Treatment Import and Export
      • 5.6 Japan End-Stage Kidney Disease Treatment Market Analysis
        • 5.6.1 Japan End-Stage Kidney Disease Treatment Production
        • 5.6.2 Japan End-Stage Kidney Disease Treatment Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan End-Stage Kidney Disease Treatment Import and Export
      • 5.7 Southeast Asia End-Stage Kidney Disease Treatment Market Analysis
        • 5.7.1 Southeast Asia End-Stage Kidney Disease Treatment Production
        • 5.7.2 Southeast Asia End-Stage Kidney Disease Treatment Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia End-Stage Kidney Disease Treatment Import and Export
      • 5.8 India End-Stage Kidney Disease Treatment Market Analysis
        • 5.8.1 India End-Stage Kidney Disease Treatment Production
        • 5.8.2 India End-Stage Kidney Disease Treatment Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India End-Stage Kidney Disease Treatment Import and Export

      6 End-Stage Kidney Disease Treatment Segment Market Analysis (by Type)

      • 6.1 Global End-Stage Kidney Disease Treatment Production by Type
      • 6.2 Global End-Stage Kidney Disease Treatment Revenue by Type
      • 6.3 End-Stage Kidney Disease Treatment Price by Type

      7 End-Stage Kidney Disease Treatment Segment Market Analysis (by Application)

      • 7.1 Global End-Stage Kidney Disease Treatment Consumption by Application
      • 7.2 Global End-Stage Kidney Disease Treatment Consumption Market Share by Application (2014-2019)

      8 End-Stage Kidney Disease Treatment Major Manufacturers Analysis

      • 8.1 BLR Bio LLC
        • 8.1.1 BLR Bio LLC End-Stage Kidney Disease Treatment Production Sites and Area Served
        • 8.1.2 BLR Bio LLC Product Introduction, Application and Specification
        • 8.1.3 BLR Bio LLC End-Stage Kidney Disease Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 CTI BioPharma Corp
        • 8.2.1 CTI BioPharma Corp End-Stage Kidney Disease Treatment Production Sites and Area Served
        • 8.2.2 CTI BioPharma Corp Product Introduction, Application and Specification
        • 8.2.3 CTI BioPharma Corp End-Stage Kidney Disease Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 F. Hoffmann-La Roche Ltd
        • 8.3.1 F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Production Sites and Area Served
        • 8.3.2 F. Hoffmann-La Roche Ltd Product Introduction, Application and Specification
        • 8.3.3 F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Novartis AG
        • 8.4.1 Novartis AG End-Stage Kidney Disease Treatment Production Sites and Area Served
        • 8.4.2 Novartis AG Product Introduction, Application and Specification
        • 8.4.3 Novartis AG End-Stage Kidney Disease Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Prolong Pharmaceuticals LLC
        • 8.5.1 Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Production Sites and Area Served
        • 8.5.2 Prolong Pharmaceuticals LLC Product Introduction, Application and Specification
        • 8.5.3 Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 VESSL Therapeutics Ltd
        • 8.6.1 VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Production Sites and Area Served
        • 8.6.2 VESSL Therapeutics Ltd Product Introduction, Application and Specification
        • 8.6.3 VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served

      9 Development Trend of Analysis of End-Stage Kidney Disease Treatment Market

      • 9.1 Global End-Stage Kidney Disease Treatment Market Trend Analysis
        • 9.1.1 Global End-Stage Kidney Disease Treatment Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 End-Stage Kidney Disease Treatment Regional Market Trend
        • 9.2.1 North America End-Stage Kidney Disease Treatment Forecast 2019-2025
        • 9.2.2 Europe End-Stage Kidney Disease Treatment Forecast 2019-2025
        • 9.2.3 China End-Stage Kidney Disease Treatment Forecast 2019-2025
        • 9.2.4 Japan End-Stage Kidney Disease Treatment Forecast 2019-2025
        • 9.2.5 Southeast Asia End-Stage Kidney Disease Treatment Forecast 2019-2025
        • 9.2.6 India End-Stage Kidney Disease Treatment Forecast 2019-2025
      • 9.3 End-Stage Kidney Disease Treatment Market Trend (Product Type)
      • 9.4 End-Stage Kidney Disease Treatment Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 End-Stage Kidney Disease Treatment Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global End-Stage Kidney Disease Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on End-Stage Kidney Disease Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall End-Stage Kidney Disease Treatment market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of End-Stage Kidney Disease Treatment in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their End-Stage Kidney Disease Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        BLR Bio LLC
        CTI BioPharma Corp
        F. Hoffmann-La Roche Ltd
        Novartis AG
        Prolong Pharmaceuticals LLC
        VESSL Therapeutics Ltd
        ...

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        MK-3866
        Pacritinib
        Sanguinate
        Tesidolumab
        Others

        Segment by Application
        Clinic
        Hospital
        Others

        Buy now